DIM
BDTX icon

DLK Investment Management’s Black Diamond Therapeutics BDTX Stock Holding History

DLK Investment Management’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.6K Sell
16,215
-1,985
-11% -$4.86K 0.03% 83
2026
Q1 		$38.8K Hold
18,200
– – 0.02% 87
2025
Q4 		$44.2K Sell
18,200
-2,000
-10% -$7.08K 0.02% 84
2025
Q3 		$76.6K Hold
20,200
– – 0.03% 80
2025
Q2 		$50.1K Buy
20,200
+4,200
+26% +$8.1K 0.02% 79
2025
Q1 		$24.8K Hold
16,000
– – 0.01% 81
2024
Q4 		$34.2K Sell
16,000
-215
-1% -$616 0.01% 80
2024
Q3 		$70.5K Hold
16,215
– – 0.03% 94
2024
Q2 		$75.6K Hold
16,215
– – 0.03% 86
2024
Q1 		$82.2K Hold
16,215
– – 0.03% 88
2023
Q4 		$45.6K Buy
+16,215
New +$38K 0.02% 90

Other funds holding BDTX

PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

DLK Investment Management's BDTX Position: Q2 2026 in Review

DLK Investment Management reduced its Black Diamond Therapeutics (BDTX) stake by 11% in Q2 2026, selling an estimated $4.86K and leaving 16,215 shares worth $75.6K. The position accounts for 0.03% of the portfolio, ranked #83.

DLK Investment Management first reported a position in BDTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $82.2K in Q1 2024. 10 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • DLK Investment Management held 16,215 shares of Black Diamond Therapeutics worth $75.6K as of Q2 2026.
  • DLK Investment Management sold 1,985 Black Diamond Therapeutics shares in Q2 2026, an estimated $4.86K.
  • Black Diamond Therapeutics made up 0.03% of DLK Investment Management's portfolio in Q2 2026, its #83 holding.
  • DLK Investment Management first reported a position in Black Diamond Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • DLK Investment Management's Black Diamond Therapeutics position peaked at $82.2K in Q1 2024.
  • 10 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on DLK Investment Management's 13F filing for Q2 2026, filed 14 Jul 2026.